Clinical Trial Update: Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of topical clascoterone 1% cream (WINLEVI) for facial acneiform rosacea; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papular-pustular Rosacea
• Papulopustular Rosacea

Drugs mentioned

• Winlevi (clascoterone)

Snippet

Sponsor: Narrows Institute for Biomedical Research | Conditions: Papular-pustular Rosacea, Papulopustular Rosacea (PPR) | Phase 2 | Status: RECRUITING